Discussions

Gene Therapy Market Size to Cross $16.5 Billion by 2035 | Exclusive Report by Roots Analysis

The global gene therapy market, valued at USD 2.4 billion in 2024, is estimated to reach USD 3.4 billion in 2025 and USD 16.5 billion by 2035, representing a CAGR of 17.0% during the forecast period.

Gene therapies are a class of biologic products designed to alter the genetic material of an individual to treat rare diseases caused by inherited genetic mutations. These therapies are developed to address the underlying genetic cause of a disease, either by introducing a healthy version of the mutated gene or by inactivating the functions of disease-causing genes within the body. Currently, 20 gene therapies are commercially available for the treatment of various genetic disorders, including spinal muscular atrophy and sickle cell disease. Additionally, more than 370 candidates are currently being evaluated across various phases of clinical trials and around 920 gene therapies are being developed across preclinical and discovery stages of development. Further, it is worth highlighting that these therapies have demonstrated tremendous potential in revolutionizing the treatment of chronic conditions, with promising results in achieving complete disease remission. As such, the demand for gene therapies is increasing substantially, thereby encouraging gene therapy companies and non-industry players to enhance their R&D capabilities in order to develop and advance a greater number of therapies towards the commercial market. Driven by the growing demand for targeted therapies, the gene therapy market size is poised to experience a noteworthy increase during the forecast period.

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/gene-therapies-market/268.html

By Therapeutic Area, muscle disorders are anticipated to capture the largest share of the global gene therapy market

The muscle disorders segment captures the largest revenue share of more than 70% in the gene therapy market, in 2024.
The cardiovascular disorders segment is anticipated to witness the highest market growth rate of 47.98%, during the forecast period.

By Type of Vector, Adeno-associated virus vector is anticipated to capture the largest share of the global gene therapy market

Adeno-associated virus vectors segment captures the largest revenue share of close to 80% in the gene therapy market, in 2024.
Non-viral vectors segment is anticipated to be the fastest growing segment in gene therapy market with a CAGR of 73.26%, during the forecast period.

By Type of Therapy, Gene Augmentation are anticipated to capture the largest share of the global gene therapy market

The gene augmentation segment captures the largest revenue share of 94% in the gene therapy market, in 2024.
The gene regulation segment is anticipated to witness a higher CAGR of 53.10%, during the forecast period.

By Type of Gene Delivery Method, In vivo gene delivery segment is anticipated to capture the largest share of the global gene therapy market

The in vivo gene delivery segment captures the largest revenue share of 91% in the gene therapy market, in 2024.
The ex vivo gene delivery segment is anticipated to witness the highest market growth rate of 30.67%, during the forecast period.

By Route of Administration, intravenous segment is anticipated to capture the largest share of the global gene therapy market

The intravenous route segment captures the largest revenue share of close to 85% in the gene therapy market, in 2024.
The intramuscular route segment is anticipated to witness a higher market growth rate of 31.98%, during the forecast period.

Gene Therapy Market – Regional Analysis

North America dominates the gene therapy market and accounts for the largest revenue share of more than 60% in 2024.
In Europe, the gene therapy market is anticipated to witness a higher growth rate of 20.79%, during the forecast period.

Key Companies Profiled

The gene therapy market report also includes profiles of key players (listed below) that are involved in the development of gene therapies:

Amgen
Artgen Biotech
BioMarin Pharmaceutical
bluebird bio
CRISPR Therapeutics
CSL Behring
Ferring Pharmaceuticals
Kolon TissueGene
Krystal Biotech
Novartis
Orchard Therapeutics
Pfizer
PTC Therapeutics
Sarepta Therapeutics
Shanghai Sunway Biotech
Sibiono GeneTech
Spark Therapeutics

Gene Therapy Market – Key Segments

Gene Therapy Market, by Therapeutic Area

Cardiovascular Disorders
Dermatological Disorders
Genetic Disorders
Hematological Disorders
Metabolic Disorders
Muscle Disorders
Oncological Disorders
Ophthalmic Disorders
Other Disorders

Gene Therapy Market, by Type of Vector

Adeno-Associated Virus Vectors
Adenovirus Vectors
Herpes Simplex Virus Vectors
Lentivirus Vectors
Non-Viral Vectors
Retroviral Vectors
Other Vectors

Gene Therapy Market, by Type of Therapy

Gene Augmentation
Gene Editing
Gene Regulation
Oncolytic Immunotherapy
Other Therapies

Gene Therapy Market, by Type of Gene Delivery Method

In vivo
Ex vivo

Gene Therapy Market, by Route of Administration

Intramuscular Route
Intratumoral Route
Intravenous Route
Subretinal Route
Other Routes of Administration

Gene Therapy Market, by Geographical Region

North America
Europe
Asia
Latin America
Rest of the World

About Roots Analysis**

Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors.

Why Use Roots Analysis in era of Artificial Intelligence?

Tailored Insights
Robust Methodology
Smart Decisions Made Easy
By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry.

Services Offered:

Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work)
Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors.

They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans.

Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation.

Subscription Services (bundled services supporting multiple topics and domains for a firm)

With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats.

The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively.

Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights.

Contact Details for Roots Analysis

Chief Executive: Gaurav Chaudhary

Email: [email protected]

Website: https://www.rootsanalysis.com/